BD Phoenix™ PMIC-106 448416Recalls & reported problems
Becton, Dickinson And Company · BD Phoenix™ PMIC-106 · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 12
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 12 adverse event reports that list this exact device (DI 30382904484164), received between Nov 16, 2021 and Jun 12, 2026 — classified as 12 malfunctions.
The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (12 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Incorrect, Inadequate or Imprecise Result or Readings12
Patient problems
- No Clinical Signs, Symptoms or Conditions12
Recent adverse event reports
The 12 most recent of 12 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 12, 2026Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ PMIC-106 A PATIENT ISOLATE (METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS) WAS IDENTIFIED AS A METHICILLIN-SENSITIVE STAPHYLOCOCCUS AUREUS. THE USER VERIFIED THE FINAL RESULT USING CEPHEID XPERT. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. THIS IS REPORT 5 OF 6.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25488315 ↗MalfunctionAug 29, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ PMIC-106 A PATIENT BLOOD CULTURE ISOLATE METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) WAS MISIDENTIFIED AS METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS (MSSA). THE USER NOTED THE ISOLATE'S FINAL RESULT WAS VERIFIED USING PCR AND DISC DIFFUSION AND REPEAT TESTING. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 1 OF 2.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22925924 ↗MalfunctionAug 29, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ PMIC-106 A PATIENT BLOOD CULTURE ISOLATE METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) WAS MISIDENTIFIED AS METHICILLIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS (MSSA). THE USER NOTED THE ISOLATE'S FINAL RESULT WAS VERIFIED USING PCR AND DISC DIFFUSION AND REPEAT TESTING. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 2 OF 2.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22925913 ↗MalfunctionJul 14, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ PMIC-106 AN UNSPECIFIED NUMBER OF PATIENT SAMPLES RESULTED IN NO MIC FOR THE DRUG TRIMETHOPRIM / SULFAMETHOXAZOLE (SXT). NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19737566 ↗MalfunctionJun 7, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ PMIC-106 NO MIC WAS GIVEN FOR THE DRUG LEVOFLOXACIN FOR A PATIENT ENTEROCOCCUS FAECIUM ISOLATE (424161535982). NO HEALTH IMPACT OR CONSEQUENCE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19481600 ↗MalfunctionMay 24, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ PMIC-106 NO MIC WAS GIVEN FOR THE DRUG TRIMETHOPRIM / SULFAMETHOXAZOLE (SXT) FOR A PATIENT S. AUREUS ISOLATE (424161535968). NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 2 OF 2.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19393291 ↗MalfunctionMay 24, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE USING THE BD PHOENIX¿ PMIC-106 NO MIC WAS GIVEN FOR THE DRUG TRIMETHOPRIM / SULFAMETHOXAZOLE (SXT) FOR A PATIENT S. AUREUS ISOLATE (424161535977). NO HEALTH IMPACT OR CONSEQUENCE REPORTED. REPORT 1 OF 2.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19393284 ↗MalfunctionApr 29, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
REPORT 1 OF 3: IT WAS REPORTED THAT WHILE TESTING WITH BD PHOENIX¿ PMIC-106, NO MIC RESULTS WERE OBTAINED FOR ANTIBIOTIC TRIMETHOPRIM-SULFAMETHOXAZOLE ON A PATIENT SAMPLE. THERE WERE NO HEALTH IMPACT OR CONSEQUENCES REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19201750 ↗MalfunctionApr 29, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
REPORT 3 OF 3: IT WAS REPORTED THAT WHILE TESTING WITH BD PHOENIX¿ PMIC-106, NO MIC RESULTS WERE OBTAINED FOR ANTIBIOTIC TRIMETHOPRIM-SULFAMETHOXAZOLE ON A PATIENT SAMPLE. THERE WERE NO HEALTH IMPACT OR CONSEQUENCES REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19201744 ↗MalfunctionApr 29, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
REPORT 2 OF 3: IT WAS REPORTED THAT WHILE TESTING WITH BD PHOENIX¿ PMIC-106, NO MIC RESULTS WERE OBTAINED FOR ANTIBIOTIC TRIMETHOPRIM-SULFAMETHOXAZOLE ON A PATIENT SAMPLE. THERE WERE NO HEALTH IMPACT OR CONSEQUENCES REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19201741 ↗MalfunctionApr 3, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED WHILE TESTING WITH BD PHOENIX¿ PMIC-106. NO MIC RESULT WAS OBTAINED FOR TRIMETHOPRIM-SULFAMETHOXAZOLE. THERE WAS NO HEALTH IMPACT OR CONSEQUENCES REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19037899 ↗MalfunctionNov 16, 2021Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED THAT THE BD PHOENIX¿ PMIC-106 MISIDENTIFIED 2 RESULTS, WITH THE TOP ANALYZER READING THEM DIFFERENTLY THAN THE BOTTOM ONE. THERE WAS NO INDICATION OF CONFIRMATORY TESTING, AND RESULTS WERE NOT REPORTED TO CLINICIANS. THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "THE CUSTOMER IS REPORTING 2 SUBSEQUENCE ERRONEOUS RESULTS FROM AN E18 OBSERVED AND REPORTED" "THEY RAN 2 PATIENT PANELS IN DUPLICATE THE TOP ANALYZER READ DIFFERENTLY THAN THE BOTTOM" "NO PATIENT CARE PROVIDED BASED ON ERRONEOUS RESULTS."
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12822031 ↗
Other SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION devices
- BD Phoenix™ M50 Automated Microbiology System 443624Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION3 recalls417 reports
- BD Phoenix™ NMIC/ID-307 449289Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION529 reports
- BD Phoenix™ PMIC/ID-107 448607Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION2 recalls169 reports
- BD Phoenix™ NMIC-306 449292Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION1 recall143 reports
- VITEK® 2 AST-GP67Biomerieux , Inc. · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation2 recalls83 reports
- BD Phoenix™ AST Broth 246003Becton, Dickinson And Company · SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION182 reports
- VITEK® 2 AST-GP75Biomerieux , Inc. · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation2 recalls52 reports
- VITEK® 2 AST-GP78Biomerieux , Inc. · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation2 recalls41 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page